litlas
Log inCreate account

Alexander Knuth

Active 1984–2021

74
Papers
19,672
Citations
68
h-index
74
i10-index

Citations

Citations per year for Alexander Knuth1984: 1 citations1985: 6 citations1986: 3 citations1987: 2 citations1988: 2 citations1989: 7 citations1990: 5 citations1991: 7 citations1992: 20 citations1993: 17 citations1994: 26 citations1995: 23 citations1996: 17 citations1997: 25 citations1998: 58 citations1999: 88 citations2000: 130 citations2001: 156 citations2002: 200 citations2003: 181 citations2004: 179 citations2005: 159 citations2006: 121 citations2007: 102 citations2008: 133 citations2009: 124 citations2010: 135 citations2011: 119 citations2012: 101 citations2013: 112 citations2014: 102 citations2015: 113 citations2016: 129 citations2017: 113 citations2018: 112 citations2019: 343 citations2020: 406 citations2021: 356 citations2022: 292 citations2023: 237 citations2024: 280 citations2025: 132 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,735 citing papers, 28.3% of this breakdownChina: 581 citing papers, 9.5% of this breakdownGermany: 464 citing papers, 7.6% of this breakdownUnited Kingdom: 315 citing papers, 5.1% of this breakdownItaly: 286 citing papers, 4.7% of this breakdownJapan: 246 citing papers, 4% of this breakdownFrance: 244 citing papers, 4% of this breakdownSwitzerland: 208 citing papers, 3.4% of this breakdownBelgium: 166 citing papers, 2.7% of this breakdownCanada: 166 citing papers, 2.7% of this breakdownNetherlands: 158 citing papers, 2.6% of this breakdownSpain: 156 citing papers, 2.5% of this breakdown
0%28.3%Other 22.9%

Institutions

Fields

  • Medicine44.1%
  • Immunology and Microbiology34%
  • Biochemistry, Genetics and Molecular Biology17.9%
  • Engineering1.3%
  • Materials Science0.7%
  • Environmental Science0.4%
  • Other1.6%

Topics

  • Immunotherapy and Immune Responses13.6%
  • Cancer Immunotherapy and Biomarkers7.5%
  • Immune Cell Function and Interaction5.4%
  • CAR-T cell therapy research4.6%
  • T-cell and B-cell Immunology3.8%
  • vaccines and immunoinformatics approaches3.6%
  • Other61.5%

Coauthors

All papers

Open in search
  1. Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

    Authors: Hans von der Maase, Steen Werner Hansen, J.T. Roberts, Luigi Dogliotti, T. Oliver, Malcolm J. Moore, I. Bodrogi, Peter Albers, Alexander Knuth, Christian Lippert, Pierre Kerbrat, Pedro Sánchez‐Rovira, Peter Wersäll, Simon Cleall, D. Roychowdhury, Irene Tomlin, Carla Visseren‐Grul, PierFranco Conte - Journal of Clinical Oncology 2000 cited by 2,286

  2. A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

    Authors: Martin Sebastian, Andreas Schröder, Birgit Scheel, Henoch S. Hong, Anke Muth, Lotta von Boehmer, Alfred Zippelius, Frank Mayer, Martin Reck, Djordje Atanackovic, Michael Thomas, Folker Schneller, J. Stöhlmacher, Helga Bernhard, A Gröschel, Thomas Lander, Jochen Probst, Tanja Strack, V. Wiegand, Ulrike Gnad-Vogt, Karl‐Josef Kallen, Ingmar Hoerr, Florian von der Muelbe, Mariola Fotin‐Mleczek, Alexander Knuth, Sven D. Koch - Cancer Immunology Immunotherapy 2019 cited by 204

  3. Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation

    Authors: Anurag Gupta, Hans Christian Probst, Van Vuong, Alexandro Landshammer, Sabine Muth, Hideo Yagita∥, Reto A. Schwendener, Martin Pruschy, Alexander Knuth, Maries van den Broek - The Journal of Immunology 2012 cited by 453

  4. Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

    Authors: Stefanie Hiltbrunner, Christian Britschgi, Petra Schuberth, Lorenz Bankel, Thi Dan Linh Nguyen‐Kim, P. Gulati, Walter Weder, Isabelle Opitz, Olivia Lauk, Claudio Caviezel, Hans Bachmann, Annett Tabor, Petra Schröder, Alexander Knuth, Christian Münz, Rolf A. Stahel, Onur Boyman, Christoph Renner, Ulf Petrausch, Alessandra Curioni‐Fontecedro - Annals of Oncology 2020 cited by 88

  5. Classification of current anticancer immunotherapies

    Authors: Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean‐Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa M. Coussens, Madhav V. Dhodapkar, Alexander Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek D. Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Paweł Kaliński, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, J P Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J.M. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, A. Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer A. Rizvi, Catherine Sautès‐Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva‐Santos, Mark J. Smyth, Daniel E. Speiser, Radek Špíšek, Pramod K. Srivastava, James E. Talmadge, Éric Tartour, Sjoerd H. van der Burg, Benoı̂t J. Van den Eynde, Richard G. Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou, Guido Kroemer - Oncotarget 2014 cited by 470

  6. Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

    Authors: Salah‐Eddin Al‐Batran, J. T. Hartmann, Stephan Probst, Harald Schmalenberg, Stephan Hollerbach, Ralf‐Dieter Hofheinz, Volker Rethwisch, G. Seipelt, Nils Homann, G. Wilhelm, Gunter Schuch, Jan Stoehlmacher, Hans Günter Derigs, Susanna Hegewisch‐Becker, Johannes Grossmann, Claudia Pauligk, Akin Atmaca, Carsten Bokemeyer, Alexander Knuth, Elke Jäger - Journal of Clinical Oncology 2008 cited by 784

  7. Virus‐like particles for vaccination against cancer

    Authors: Mona O. Mohsen, Daniel E. Speiser, Alexander Knuth, Martin F. Bachmann - Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology 2019 cited by 123

  8. A phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells

    Authors: A. Curioni, Christian Britschgi, Stefanie Hiltbrunner, Lorenz Bankel, P. Gulati, Walter Weder, Isabelle Opitz, Olivia Lauk, Claudio Caviezel, Alexander Knuth, Christian Münz, C. Renner, Rolf A. Stahel, Ulf Petrausch - Annals of Oncology 2019 cited by 53

  9. Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine

    Authors: Mona O. Mohsen, Monique Vogel, Carsten Riether, Julius Müller, Silvia Salatino, Nicola Ternette, Ariane C. Gomes, Gustavo Cabral‐Miranda, Aadil El-Turabi, Christiane Ruedl, Thomas M. Kündig, Said Dermime, Alexander Knuth, Daniel E. Speiser, Martin F. Bachmann - Frontiers in Immunology 2019 cited by 56

  10. Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response

    Authors: Laura Surace, Veronika Lysenko, A. Fontana, Virginia Cecconi, Hans Janßen, Antonela Bicvic, Michał Okoniewski, Martin Pruschy, Reinhard Dummer, Jacques Neefjes, Alexander Knuth, Anurag Gupta, Maries van den Broek - Immunity 2015 cited by 178

  11. Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors

    Authors: Volker Lennerz, Stefanie Groß, Elisa Gallerani, Cristiana Sessa, Nicolas Mach, Steffen Boehm, Dagmar Hess, Lotta von Boehmer, Alexander Knuth, Adrian F. Ochsenbein, Ulrike Gnad-Vogt, Juergen Zieschang, Ulf Forssmann, Thomas Woelfel, Eckhart Kaempgen - Cancer Immunology Immunotherapy 2014 cited by 126

  12. Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

    Authors: Mona O. Mohsen, Matthew D. Heath, Gustavo Cabral‐Miranda, Cyrill Lipp, Andris Zeltiņš, Marcos Sande-Melón, Jens V. Stein, Carsten Riether, Elisa S. Roesti, Lisha Zha, Paul Engeroff, Aadil El-Turabi, Thomas M. Kündig, Monique Vogel, Murray Skinner, Daniel E. Speiser, Alexander Knuth, Matthias Krämer, Martin F. Bachmann - Journal for ImmunoTherapy of Cancer 2019 cited by 59

  13. Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma

    Authors: Stefanie R. Dannenmann, Julia Thielicke, Martina Stöckli, Claudia Matter, Lotta von Boehmer, Virginia Cecconi, Thomas Hermanns, Lukas J. Hefermehl, Peter Schraml, Holger Moch, Alexander Knuth, Maries van den Broek - OncoImmunology 2013 cited by 168

  14. Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

    Authors: Elke Jäger, Yao-Tseng Chen, Jan W. Drijfhout, Julia Karbach, Mark Ringhoffer, Dirk Jäger, Michael Arand, Hisashi Wada, Yuji Noguchi, Elisabeth Stockert, Lloyd J. Old, Alexander Knuth - The Journal of Experimental Medicine 1998 cited by 725

  15. NY‐ESO‐1: Review of an Immunogenic Tumor Antigen

    Authors: Sacha Gnjatic, Hiroyoshi Nishikawa, Achim A. Jungbluth, Ali O. Güre, Gerd Ritter, Elke Jäger, Alexander Knuth, Yao‐Tseng Chen, Lloyd J. Old - Advances in cancer research 2006 cited by 455

  16. Aldara activates TLR7-independent immune defence

    Authors: Anne Walter, Mathias Schäfer, Virginia Cecconi, Claudia Matter, Mirjana Urosevic‐Maiwald, Benedetta Belloni, Nicola Schönewolf, Reinhard Dummer, Wilhelm Bloch, Sabine Werner, Hans‐Dietmar Beer, Alexander Knuth, Maries van den Broek - Nature Communications 2013 cited by 262

  17. Consensus nomenclature for CD8+T cell phenotypes in cancer

    Authors: Lionel Apétoh, Mark J. Smyth, Charles G. Drake, Jean-Pierre Abastado, Ron N. Apte, Maha Ayyoub, Jean‐Yves Blay, Marc Bonneville, Lisa H. Butterfield, Anne Caignard, Chiara Castelli, Federica Cavallo, Esteban Celis, Lieping Chen, Mario P. Colombo, Begoña Comı́n-Anduix, George Coukos, Madhav V. Dhodapkar, Glenn Dranoff, Ian H. Frazer, Wolf H. Fridman, Dmitry I. Gabrilovich, Eli Gilboa, Sacha Gnjatic, Dirk Jäger, Paweł Kaliński, Howard L. Kaufman, Rolf Kiessling, John M. Kirkwood, Alexander Knuth, Roland Liblau, Michael T. Lotze, Enrico Lugli, Francesco M. Marincola, Ignacio Melero, Cornelis J.M. Melief, Thorsten R. Mempel, Elizabeth A. Mittendorf, Kunle Odun, Willem W. Overwijk, A. Karolina Palucka, Giorgio Parmiani, Antoni Ribas, Pedro Romero, Robert D. Schreiber, Gerold Schuler, Pramod K. Srivastava, Éric Tartour, Danila Valmori, Sjoerd H. van der Burg, Pierre van der Bruggen, Benoı̂t J. Van den Eynde, Ena Wang, Weiping Zou, Theresa L. Whiteside, Daniel E. Speiser, Drew M. Pardoll, Nicholas P. Restifo, Ana C. Anderson - OncoImmunology 2015 cited by 136

  18. Rational development of high-affinity T-cell receptor-like antibodies

    Authors: Guillaume Stewart-Jones, Andreas Wadle, Anja Hombach, Eugene Shenderov, Gerhard Held, Eliane Fischer, Sascha Kleber, Natko Nuber, Frank Stenner, Stefan Bauer, Andrew McMichael, Alexander Knuth, Hinrich Abken, Andreas Hombach, Vincenzo Cerundolo, E. Yvonne Jones, Christoph Renner - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 130

  19. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

    Authors: Pierre van der Bruggen, Catia Traversari, Patrick Chomez, Christophe Lurquin, Etienne De Plaen, Benoı̂t J. Van den Eynde, Alexander Knuth, Thierry Boon - Science 1991 cited by 3,535

  20. Survey of naturally occurring CD4 + T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

    Authors: Sacha Gnjatic, Djordje Atanackovic, Elke Jäger, Mitsutoshi Matsuo, Annamalai Selvakumar, Nasser K. Altorki, Robert G. Maki, Bo Dupont, Gerd Ritter, Yao‐Tseng Chen, Alexander Knuth, Lloyd J. Old - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 201

  21. Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL

    Authors: Ji‐Li Chen, P. Rod Dunbar, Uzi Gileadi, Elke Jäger, Sacha Gnjatic, Yasuhiro Nagata, Elisabeth Stockert, Dennis Panicali, Yao‐Tseng Chen, Alexander Knuth, Lloyd J. Old, Vincenzo Cerundolo - The Journal of Immunology 2000 cited by 175

  22. γ-Radiation Promotes Immunological Recognition of Cancer Cells through Increased Expression of Cancer-Testis Antigens In Vitro and In Vivo

    Authors: Anu Sharma, Beata Bode, Roland H. Wenger, Kuno Lehmann, Alessandro A. Sartori, Holger Moch, Alexander Knuth, Lotta von Boehmer, Maries van den Broek - PLoS ONE 2011 cited by 131

  23. A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

    Authors: Elisabeth Stockert, Elke Jäger, Yao‐Tseng Chen, Matthew J. Scanlan, Ivan Gout, Julia Karbach, Michael Arand, Alexander Knuth, Lloyd J. Old - The Journal of Experimental Medicine 1998 cited by 696

  24. Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

    Authors: Elke Jäger, Yasuhiro Nagata, Sacha Gnjatic, Hisashi Wada, Elisabeth Stockert, Julia Karbach, P. Rod Dunbar, Sang Yull Lee, Achim A. Jungbluth, Dirk Jäger, Michael Arand, Gerd Ritter, Vincenzo Cerundolo, Bo Dupont, Yao‐Tseng Chen, Lloyd J. Old, Alexander Knuth - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 398